Clinical Trial Results:
A Phase III single-blind, randomised, placebo controlled trial of long term therapy in patients with stable COPD using Moxifloxacin, Azithromycin, and Doxycycline: a Bayesian decision analysis, including other criteria, will be used to distinguish the optimal antibiotic treatment.
Summary
|
|
EudraCT number |
2011-001063-43 |
Trial protocol |
GB |
Global completion date |
04 Jul 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Apr 2017
|
First version publication date |
12 Apr 2017
|
Other versions |
|
Summary report(s) |
Development of an optimal antibiotic regime for long-term therapy in stable COPD |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.